Brief: Beroni Group To Launch Its Advanced U.S. FDA-Approved Virus Diagnostic Kit To Help Combat Global Outbreaks Of Zika, Dengue, Chikungunya And West Nile Viruses
24/10/2019 14:31
Oct 24 (Reuters) - Beroni Group Ltd BTG.NH :
* BERONI GROUP TO LAUNCH ITS ADVANCED US FDA-APPROVED VIRUS
DIAGNOSTIC KIT TO HELP COMBAT GLOBAL OUTBREAKS OF ZIKA, DENGUE,
CHIKUNGUNYA AND WEST NILE VIRUSES
Source text for Eikon: ID:nGNX3stpMP
Further company coverage: BTG.NH
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beroni
See all newsBrief: Beroni Group’s Enhanced Covid-19 Antigen Rapid Test Kit Received CE Certification
Brief: Beroni Group Ltd Files For A U.S. IPO
Received Part Payment Of A $1.07 Mln Order For SARS-COV-2 Antigen Test Kit From A Japanese Pharma Co
Brief: Beroni Group Gets Approval For R&D Rebate From Australian Government
Brief: Beroni Group Says Study Of Its SARS-CoV-2 Antigen Test Kit Showed Overall Sensitivity Of 95%